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CHAPTER I 
INTRODUCTION 
Alkaline phosphatase (APase) has been associated with 
the thymic lymphoma by several workers. Smith (1961, 1962) 
has shown the correlation between the presence of APase and 
thymic lymphoma development in C57B1/6 and AKR strains of 
mice. Metcalf et al. (1962) observed the same kind of rela¬ 
tionship in C3H and AKR strains of mice. LagerlUf and Kaplan 
(1967)» using histochemical methods, showed that APase 
appears concurrently with the development of thymic lympho¬ 
ma. Lumb and Doell (1970) have compared APase from thymic 
lymphomas, normal adult spleen and l6-day-old embryonic 
thymus and found them to be related on the basis of bio¬ 
chemical parameters. On the basis of this observation they 
suggested that APase is a cell-coded enzyme which is dere- 
pressed in the course of malignant transformation. 
This study was undertaken to further characterize the 
APase from normal tissues and leukemic tissues and to see if 
the APase of thymic lymphoma is a derepressed enzyme as has 
been suggested by Lumb and Doell (1970). For this purpose 
the parameters of inhibition and metallic ion activation 
were used to compare the APase from normal and leukemic 
tissues. 
Inhibitors have been used for a long time in the iden- 
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tification of tissue sources of APase. Bodansky (1937) has 
used bile acids in the differentiation of APases from bone, 
kidney, intestine, and serum. Fishman et al. (1963) used 
L-phenylalanine as an organ specific, stereospecific inhib¬ 
itor of intestinal APase from rat and human intestine. Cox 
and Griffin (1967) studying the physical and chemical prop¬ 
erties of APase from mammalian tissues, cell cultures and 
E. coli reported that these various preparations of APase 
differ from each other in respect to the concentration of 
zinc and L-phenylalanine required to inhibit the enzymatic 
activity. Ethylenediamine tetraacetic acid has been used 
as an inhibitor of APase by Clark and Porteous (1965). 
APase from the rabbit intestine, when dialyzed against EDTA, 
can be reactivated by the addition of cobalt alone or mag¬ 
nesium and zinc ions together, neither magnesium nor zinc 
was effective alone (Clark and Porteous, 1965). The impor¬ 
tant observation was that zinc should not exceed an optimum 
limit. 
Preliminary studies by Williams (1971) have indicated 
that APase from thymic lymphomas is inhibited by zinc, L- 
phenylalanine and EDTA, and that EDTA inhibition is reversed 
by the addition of magnesium. These studies were undertaken 
to compare the APase from normal tissues with that from leu¬ 
kemic tissues utilizing the above parameters. 
CHAPTER II 
REVIEW OF LITERATURE 
Mouse Leukemia Viruses 
As a result of its similarity to the human disease, 
murine leukemia has teen of significant experimental inter¬ 
est for many years. The demonstration by Gross (1951) that 
a cell free extract from a spontaneously produced lymphoma 
would produce leukemia in other mice refocused attention on 
this experimental approach to an understanding of the mecha 
nism of neoplasia. 
Lieberman and Kaplan (1959) reported the leukemogenic 
activity of a cell free filtrate from a radiation-induced 
C57B1 mouse lymphoma. They observed that even non-irra- 
diated thymic implants in irradiated hosts would develop 
tumors. This phenomenon of indirect induction led them to 
believe that a latent sub-cellular agent analogous to the 
filtrable agent of spontaneous mouse leukemia reported by 
Gross (1951) is activated by irradiation and causes malig¬ 
nant transformation in susceptible lymphoid cells. Their 
results provided the first evidence for directly linking 
the external carcinogens to viruses. Haran-Ghera (1967) 
induced generalized lymphatic leukemia in C57B1 mice with 
7,12-dimethylbenz(a)anthracene. When filtrates from these 
chemically induced lymphomas were injected into the thymic 
implants in thymectomized, irradiated adult mice, 15-27 per 
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cent developed a generalized type of lymphatic leukemia. 
This report described for the first time the successful 
induction of lymphatic leukemia in adult C57B1 mice. Doell 
and Mathieson (1970) shoved the induction of thymic lympho¬ 
mas in C57B1 mice and W/Fu rats injected intrathymically 
during neonatal life with a virus later named C57LV (Doell 
and Mathieson, 1971). This virus was isolated from 6-mer- 
captopurine-induced thymic lymphoma and maintained through 
serial passages. Ferrer and Kaplan (1968) have shown by 
antigenic analysis that the virus induced by irradiation 
(RadLV) is related to Gross type virus. Doell and Mathieson 
(1971) have also shown the same kind of relationship be¬ 
tween Gross virus, RadLV and C57LV utilizing the immuno¬ 
fluorescence test. 
Role of APase in Mouse Leukemia 
Smith (1961, 1962) has utilized histochemical tech¬ 
niques in the study of thymuses of AKR and irradiated 
C57B1/6 strains of mice and has shown the association of 
APase with the thymic lymphomas in both of these strains of 
mice. Her studies indicated a lower incidence of positive 
reactive cells in the thigh-shielded mice. Kaplan and Brown 
(1952) have also shown a lower incidence of thymic lymphoma 
development in the thigh-shielded mice. Smith (1962) there¬ 
fore correlated the appearance of APase with the development 
of lymphoma. Her histochemical results emphasized the 
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correlation between sites of reactivity in the thymus and 
the development of induced lymphoma. In the initial stages 
after irradiation when the lobes looked normal there were 
clusters of positive cells among negative lymphocytes. She 
suggested that these histochemical changes might precede 
the histological changes. Metcalf et al. (1962) have stud¬ 
ied the APase activity of mouse lymphoma tissue from the AKR 
mice, (leukemia incidence 90%) and from the low leukemic C3H 
strain of mice (leukemia incidence 5%). They found that 
APase activity of the thymic lymphoma is higher as compared 
with the normal thymic tissues. According to one of their 
histochemical observations, the thymic lymphoma APase is 
associated with the lymphocytes. They also found higher 
APase activity in preleukemic thymuses, but since the activ¬ 
ity could not be detected in the lymphocytes, they concluded 
that APase activity appears in the lymphocytes only after 
the cells have become frankly neoplastic. On the whole 
their results did not justify the conclusion that higher 
content of APase activity in the lymphoma tissue is a neces¬ 
sary part of the neoplastic transformation. Siegler and 
Rich (1967) have studied the significance of increased APase 
activity in thymic lymphomas. The Gomori histochemical 
technique which they used for the demonstration of APase 
activity did not show APase in the early stages of lymphoma 
development. The lack of sensitivity of the staining tech- 
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nique for APase might have been responsible for the negative 
results. Lagerlttf and Kaplan (1967) have demonstrated by 
the more sensitive azo dye technique that APase is asso¬ 
ciated with the neoplastic cells and is formed concurrent 
with neoplastic transformation. They performed different 
experiments such as adrenalectomy, thymectomy and irradia¬ 
tion of mice with shielded thighs to rule out a connection 
between APase and non-malignant cell proliferation. Lumb 
and Doell (1970) using the biochemical parameters have 
shown that APase of thymic lymphoma resembles normal adult 
spleen and l6-day-old embryonic thymus APase activities. 
They postulated that APase of thymic lymphomas appears due 
to the derepression of embryonic functions. 
Use of Inhibitors in the Identification 
of APase Isoenzymes 
Inhibitors have been used for a long time in the iden¬ 
tification of tissues sources of APase isoenzymes. Cloetens 
(1939) and Drill and Riggs (19^6), utilizing cyanide inhibi¬ 
tion in the identification, showed two types of APase in 
animal tissues. Bodansky (1937) used bile acids in distin¬ 
guishing the APase from bone, kidney, intestine, and serum. 
Fishman et al. (1962), while evaluating the effect of 130 
compounds on the APases from different rat tissues, found 
that L-phenylalanine preferentially inhibited intestinal 
APase. Zinc sulfate inhibited bone, liver, lung and kidney 
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APase, but not intestinal or blood serum APase. Cox and 
Griffin (1967) have studied the various physical and chem¬ 
ical properties of APases from mammalian tissues, cell cul¬ 
tures and IS. coli and reported that these various enzyme 
preparations differ from one another with respect to the 
concentration of zinc sulfate and L-phenylalanine required 
to inhibit their enzymatic activities. Eaton and Moss 
(1967), while studying the orthophosphatase and pyrophos¬ 
phatase activities of human intestinal and liver APases, 
found that L-phenylalanine inhibited both the activities of 
intestinal APase but did not affect either of the activities 
of liver APase. Rufo and Fishman (1972) used L-Homoarginine, 
a specific inhibitor of liver type APase, to demonstrate 
the presence of APase in the rat intestine. Belle (1972) 
used a number of inhibitors in the identification of APases 
from several tissues of the dog. The results showed that 
of the various inhibitors used including EDTA, L-phen¬ 
ylalanine, KCN, potassium cyanide and L-cysteine, only 
levamisole had a differentiating effect and could be used 
in the identification of canine intestinal APase. 
CHAPTER III 
MATERIALS AND METHODS 
Normal Tissues 
The normal spleen, placenta and embryo were obtained 
from young male and l6-day-pregnant female C57B1 mice re¬ 
spectively. 
Tumors 
Tumor numbers H-98, U-l and H-36 were obtained from 
mice which had been injected intrathymically during neonatal 
life with C57LV in its fourteenth passage (Doell and 
Mathieson, 1970). H-58 was a 6-mercaptopurine-induced 
tumor; H-117 was a spontaneous tumor; H-208 and H-253 were 
obtained by transplanting cells from virally induced tumors. 
Buffers 
Ammediol buffer (2-amino-2methyl-l,3-propanediol) was 
used in all the experiments at pH 10 at 37 C in a final 
concentration of 0.04 M. In all cases pH was adjusted by 
employing 1 N HC1 and IN NaOH. In the case of L-phen- 
ylalanine inhibition and EDTA inhibition and its reversal 
with magnesium ion, the appropriate amounts of these were 
added to the buffers before adjusting the final pH to 10. 
Tris (hydroxymethyl) aminomethane at pH 7 in a final con¬ 
centration of 0.1 M was used in the determination of mag¬ 




Para-nitrophenyl phosphate (p-NPP) at a final concen¬ 
tration of 3.38 mM was used as a substrate in all the ex¬ 
periments . 
Inhibitors 
Zinc sulfate, L-phenylalanine and ethylenediamine 
tetraacetic acid (EDTA), were used as inhibitors of APase. 
Zinc sulfate was used at a final concentration of 0.01 mM, 
L-phenylalanine at a final concentration of 10.0 mM and 
EDTA at final concentrations of 1.0 mM and 0.1 mM. 
Metal Ion Activator 
Magnesium chloride in final concentrations of 5.0 mM 
and 10.0 mM was used as an activator of APase. 
Preparation of Eniyme Extract 
Tissues which have been previously frozen or, in some 
cases, fresh tissues obtained from a sacrificed mouse were 
used in these experiments. A small amount of tissue was 
transferred into about 2 ml of 0.015 M NaCl solution on a 
petri dish on ice. The tissue was minced with clean 
scissors and then transferred into a glass homogenizer. 
Five ml of 0.015 M NaCl solution was added to the glass ho¬ 
mogenizer containing minced tissue. The tissue was homoge¬ 
nized thoroughly in an ice bath and then passed through three 
or four layers of cheese cloth into another clean tube. The 
extracts were dispensed into small tubes and stored at -1» C. 
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p-NPP Assay 
The assay was performed in a one-milliliter reaction 
volume. The reaction mixture contained 0.8 ml Ammediol 
buffer at pH 10.0, 0.1 ml enzyme extract and 0.1 ml p-NPP in 
a final concentration of 3.38 mM. The reaction was carried 
out at 37 C and stopped after 30 minutes by adding 2 ml 
0.5 N NaOH containing 0.1 M EDTA. The concentration of 
p-nitrophenol was determined by reading the absorbance at 
1|00 nm and referring to a calibration curve. Blanks were 
prepared in a similar way except that EDTA in NaOH was added 
before adding substrate. The average of three experimental 
tubes was calculated and the blank was subtracted from the 
average reading. 
Inhibition Experiments 
Inhibition experiments were performed in the presence 
of EDTA, zinc sulfate or L-phenylalanine, while controls 
were run without any inhibitor. Assays were run as has been 
indicated and the results were compared to control. The 
percentage of inhibition was calculated with formula: 
A - B 
% inhibition =  x 100 
A 
where "A" is the activity in the absence of any inhibitor, 
and "B" is the activity in the presence of an appropriate 
concentration of an inhibitor. 
11 
EDTA Experiments 
The inhibition experiments were run in the presence of 
1 mM and 0.1 mM EDTA. The inhibition with each of these 
concentrations was reversed by 5.0 mM and 10.0 mM magnesium 
The controls for each of these concentrations were run si¬ 
multaneously and the percentage of control was calculated. 
Magnesium Content of Tissue Extracts 
Magnesium ions are chelated by 8-hydroxy-5-quinoline 
sulfonic acid. The resulting chelate fluoresces at 500 nm 
when excited by the light of 3Ô0 nm. There is little inter 
ference from chelates of other heavy metals (Schachter, 
1959» 1961). The working reagent included final concentra¬ 
tions of buffer and 8-hydroxy-5-quinoline sulfonic acid of 
0.1 M and 0.0025 M respectively. The fluorescence spectro¬ 
photometer was warmed for an hour before use. It was ad¬ 
justed to read "0" on the scale with k ml of buffer and 
reagent. Then one lambda of tissue extract was added and 
the reading recorded. The concentrations of standards used 
included 0.5 x 10“6 M, 1.0 x 10"6 M, 2 x 10~6 M and 
3 x 10”^ M concentrations of magnesium. The standard dilu¬ 
tions of magnesium were read by zeroing with 3.9 ml of 
buffer and reagent solution and adding 0.1 ml of the stan¬ 
dard dilution. Each of the standard dilutions was read 
twice. The average values were calculated for standards 
and tissue extracts. The magnesium content of each tissue 
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was calculated by referring to the standard curve (Fig. l). 
Statistics 
A t-test analysis of variance procedure was used to 
find out whether there was a significant difference between 
APase activities of leukemic and normal tissues (Goldstein, 
1964). The data were computed at the Atlanta University 
Center Computing Center using the TTSTT subroutine of the 
Scientific Subroutine Package with an IBM (international 
Business Machines) 1130 computer. 
Fig. 1. Standard curve for the determination of magnesium 
content. Fluorescence spectrophotometry was used 
with chelating agent 8-hydroxy-5-quinoline sul¬ 
fonic acid in 0.0025 M final concentration and 
tris (hydroxymethyl) aminomethane in a final con¬ 




















Figure 2 shows the results obtained with the use of 
tine sulfate at a final concentration of 0.01 mM. There 
was a statistically significant difference between APase 
from the embryo and placenta and that from spleen and leu¬ 
kemic tissues (p < 0.01 by t test, Table 1). Embryonic 
APase is inhibited up to 32# while placental APase is 
inhibited up to 56%. Neither leukemic APase activities nor 
spleen APase activities are affected at this concentration. 
Figure 3 shows the inhibitory effect of 10.0 mM concen¬ 
tration of L-phenylalanine. The APase activities from the 
normal as well as from the leukemic tissues are partially 
inhibited at this concentration of L-phenylalanine. There 
was no statistically significant difference between the 
APase isoenzymes of normal and leukemic tissues (p > 0.01, 
Table l). 
Magnesium Ion Activation 
Figure 1+ shows the effect of magnesium ions on indi¬ 
vidual lymphoma APase activities and the average of tumor 
values. All of them are activated except H-253 which does 
not show any significant activation. The other tumors are 
activated to varying extents. 
lit 
Fig. 2. Inhibitory effect of zinc sulfate on the 
alkaline phosphatase activity of the leu¬ 
kemic tissues and the normal tissues. H- 
117 was a spontaneous tumor, U-l and H-3Ô 
were viral induced tumors. The normal tis¬ 
sues included were adult spleen (S), l6-day 
embryo (E), and l6-day placenta (P). Zinc 
sulfate was used in 0.01 mM final concen¬ 
tration. The experiments were performed 
at 37 C for 30 minutes with pNPP in a final 
concentration of 3.38 mM. Percent inhibi¬ 
tion is indicated by the bar. The range 
of values is shown (I 1). 
15 
TABLE I 
Statistical Comparison of Alkaline Phosphatase of Normal and Leukemic Tissues Using 
Student's t-Test 
Characteristic Tissues compared 
Calculated 
t value 
t Value for 
p=0.01* 
Zinc Inhibition Lymphoma versus Spleen -0.207 (6)** 3.71 (6) 
Lymphoma versus Embryo 6.935 (7) 3.50 (7) 
Lymphoma versus Placenta 9.513 (7) 3.50 (7) 
Spleen versus Embryo 11.502 (5) 4.03 (5) 
Spleen versus Placenta 12.193 (3) 5.84 (3) 
Placenta versus Embryo -4.988 (4) 4.60 (4) 
L-phenylalanine Inhibition Lymphoma versus Spleen -0.532 (3) 5.84 (3) 
Lymphoma versus Embryo 1.301 (5) 4.03 (5) 
Lymphoma versus Placenta -0.884 (4) 4.60 (4) 
Spleen versus Embryo 1.279 (5) 4.03 (5) 
Spleen versus Placenta -0.083 (5) 4.03 (5) 
Placenta versus Embryo 1.760 (6) 3.71 (6) 









 (8) 3.36 (8) 
TABLE I (Continued) 
Characteristic Tissues compared 
Calculated 
t value 
t Value for 
p=0.01* 
Magnesium 5*0 mM Activation 
EDTA 1.0 mM Inhibition 
Lymphoma versus Embryo -0.035 (10) 
Lymphoma versus Placenta 0.507 (11) 
Spleen versus Embryo -0.993 ( 4) 
Spleen versus Placenta -0.195 ( 6) 
Placenta versus Embryo -0.602 ( 6) 
Lymphoma versus Spleen 1.159 (10) 
Lymphoma versus Embryo -0.522 (10) 
Lymphoma versus Placenta 0.383 ( 8) 
Spleen versus Embryo -1.907 ( 6) 






 1 ( 5) 
Placenta versus Embryo -0.819 ( 6) 
Lymphoma versus Spleen 0.506 ( 7) 
Lymphoma versus Embryo 0.931 ( 6) 
Lymphoma versus Placenta 0.892 ( 6) 
3.17 (10) 
3.11 (11) 
4.60 ( 4) 
3.71 ( 6) 
3.71 ( 6) 
3.17 (10) 
3.17 (10) 
3.36 ( 8) 
3.71 ( 6) 
4.03 ( 5) 
3.71 ( 6) 
3.50 ( 7) 
3.71 ( 6) 
3.71 ( 6) 
TABLE I (Continued) 
Characteristic Tissues compared 
Calculated 
t value 
t Value for 
p=0.01* 
Spleen versus Embryo 0.771 (2) 9.92 (2) 
Spleen versus Placenta 0.729 (3) 5.84 (3) 
Placenta versus Embryo -0.083 (7) 3.50 (7) 
EDTA 0.1 mM Inhibition Lymphoma versus Spleen 1.869 (7) 3.50 (7) 
Lymphoma versus Embryo 2.779 (8) 3.36 (8) 
Lymphoma versus Placenta 3.257 (6) 3.71 (6) 
Spleen versus Embryo 0.680 (6) 3.71 (6) 
Spleen versus Placenta 1.647 (7) 3.50 (7) 
Placenta versus Embryo -1.162 (6) 3.71 (6) 
EDTA 1.0 mM Inhibition Lymphoma versus Spleen 1.733 (8) 3.36 (8) 
Lymphoma versus Embryo 2.901 (3) 5.84 (3) 
Lymphoma versus Placenta 2.317 (5) 4.03 (5) 
Spleen versus Embryo 2.160 (3) 5.84 (3) 
Spleen versus Placenta 1.376 (5) 4.03 (5) 
TABLE I (Continued) 
Characteristic Tissues compared 
Calculated 
t value 
t Value for 
p=0.01* 
Placenta versus Embryo 0.899 ( 6) 3.71 ( 6) 
EDTA 1.0 mM Inhibition Lymphoma versus Spleen 1.107 ( 4) 4.60 ( 4) 
reversed by 5.0 mM Lymphoma versus Embryo 4.070 ( 5) 4.03 ( 5) 
Magnesium Lymphoma versus Placenta 2.368 ( 4) 4.60 ( 4) 
Spleen versus Embryo 2.003 ( 6) 3.71 ( 6) 
Spleen versus Placenta 1.347 ( 7) 3.50 ( 7) 
Placenta versus Embryo 0.130 ( 6) 3.71 ( 6) 
EDTA 0.1 mM Inhibition Lymphoma versus Spleen 1.796 ( 10) 3.17 (10) 
reversed by 10.0 mM Lymphoma versus Embryo 2.291 ( 4) 4.60 ( 4) 
Magnesium Lymphoma versus Placenta 3.4o4 ( 7) 3.50 ( 7) 
Spleen versus Embryo 1.291 ( 3) 5.84 ( 3) 
Spleen versus Placenta 2.409 ( 5) 4.03 ( 5) 
Placenta versus Embryo -0.743 ( 7) 3.50 ( 7) 
TABLE I (Continued) 
Characteristic Tissues compared 
Calculated 
t value 
t Value for 
o=0.01* 
EDTA 0.1 mM Inhibition Lymphoma versus Spleen 2.016 (10) 3.17 (10) 
reversed by 5.0 mM Lymphoma versus Embryo 1.170 ( 5) 4.03 ( 5) 
Magnesium Lymphoma versus Placenta 
Spleen versus Embryo 
Spleen versus Placenta 
1.764 ( 4) 
-0.135 ( 4) 
1.l4l ( 3) 
-1.127 ( 5) 
4.60 ( 4) 
4.60 ( 4) 
5.84 ( 3) 
4.03 ( 5) 
ro 
O 
Placenta versus Embryo 
Fig. 3. Inhibitory effect of L-phenylalanine on the 
alkaline phosphatase activity of the leu¬ 
kemic tissues and the normal tissues. H- 
117 was a spontaneous tumor; U-l and H-98 
were viral induced tumors. The normal 
tissues included were adult spleen (S), 
16-day embryo (E) and 16-day placenta (P). 
L-phenylalanine was used in 10.0 mM final 
concentration. The experiments were per¬ 
formed at 37 C for 30 minutes with pNPP in 
a final concentration of 3.38 mM. Percent 
inhibition is indicated by the bar. The 
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H-25 3 H-2 0 8 S P 
Fig. k. Activating effect of magnesium ions on the 
alkaline phosphatase activity of the leu¬ 
kemic tissues. AL represents the average 
of leukemic values. H-98 and U-l were 
virus-induced tumors*; H-253 was a cell- 
transferred tumor; H-117 was a sponta¬ 
neous tumor; and H-58 was a 6-mercapto- 
purine-induced tumor. Magnesium ions 
were used in 5.0 mM and 10.0 mM final 
concentrations respectively. The experi¬ 
ments were performed at 37 C for 30 min¬ 
utes with pNPP in a final concentration 
of 3.38 mM. In each tissue bar 1 re¬ 
presents buffer alone; bar 2 represents 
buffer plus 5.0 mM magnesium chloride; 
and bar 3 represents buffer plus 10.0 mM 
magnesium chloride. 
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Figure 5 shows the effect of magnesium ions on normal 
tissue APase activities compared to the effect on lymphoma 
APase activity. The normal tissues are activated to dif¬ 
ferent extents with the concentrations of exogeneous mag¬ 
nesium ions being used. Statistically there was no sig¬ 
nificant difference (p > 0.01, Table l) between the 
isoenzymes of normal and leukemic tissues according to the 
extent of their activation. 
Magnesium Content of Different Tissue Extracts 
Fluorescence spectrophotometry was used in the deter¬ 
mination of magnesium content of different tissue extracts 
(Table 2). These experiments were done to account for 
endogeneous magnesium ions in the individual tissue extracts 
to see if this would explain the variability in the acti¬ 
vation results. The lymphoma extracts showed higher mag¬ 
nesium content but that did not correlate with activation 
levels. 
Reversal Experiments 
Figure 6 shows the inhibitory effect of 0.1 mM EDTA on 
leukemic tissues and the average of leukemic values. This 
inhibition is reversed by the addition of magnesium ions in 
5.0 mM and 10.0 mM final concentrations. The data in Table 
3 show that added magnesium ions have a significant 
(p < 0.01) reversal effect. 
Fig. 5- Activating effect of magnesium ions on the 
alkaline phosphatase activity of the normal 
tissues as compared to the average of leu¬ 
kemic values. AL represents the average 
of leukemic values which is the same as 
used in Fig. k. The normal tissues in¬ 
cluded were adult spleen (S), 16-day embryo 
(E), and 16-day placenta (P). Magnesium 
ions were used in 5.0 mM and 10.0 mM final 
concentrations respectively. The experi¬ 
ments were performed at 37 C for 30 min¬ 
utes with pNPP in a final concentration 
of 3.38 mM. In each tissue bar 1 repre¬ 
sents buffer alone; bar 2 represents 
buffer plus 5.0 mM magnesium chloride and 
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Fig. 6. Inhibition by 0.1 mM EDTA of the alkaline 
phosphatase activity of the leukemic tis¬ 
sues and its reversal with magnesium ions 
AL represents the average of leukemic val 
ues; H-9Ô and U-l were virus-induced tu¬ 
mors; H-253 was a cell-transferred tumor; 
H-117 was a spontaneous tumor; and H-5Ô 
was a 6-mercaptopurine-induced tumor. 
The magnesium ions were used in 5*0 mM 
and 10.0 mM final concentrations respec¬ 
tively. The experiments were performed 
at 37 C for 30 minutes with pNPP in a 
final concentration of 3.38 mM as a sub¬ 
strate. In each tissue bar 1 represents 
EDTA alone; bar 2 represents EDTA plus 
5.0 mM magnesium chloride and bar 3 re¬ 
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Statistical Significance of the Reversal of the EDTA Inhibited Alkaline 
Phosphatase Activity of the Leukemic and Normal Tissues by the Addition 
of Magnesium Chloride 
Tissue 
Concentration 
of EDTA in mM 
Concentration 





Lymphoma 0.1 mM 5.0 mM 18.377 (7)* 3.50 (7) 
Lymphoma 0.1 mM 10.0 mM 1*1.535 (7) 3.50 (7) 
Spleen 0.1 mM 5.0 mM 23.670 (4) 4.60 (4) 
Spleen 0.1 mM 10.0 mM 20.842 (3) 5.84 (3) 
Embryo 0.1 mM 5.0 mM 11.615 (2) 9.92 (2) 
Embryo 0.1 mM 10.0 mM 10.160 (2) 9.92 (2) 
Placenta 0.1 mM 5.0 mM 6.145 (3) 5.84 (3) 
Placenta 0.1 mM 10.0 mM 11.692 (4) 4.60 (4) 
Lymphoma 1.0 mM 5.0 mM 11.471 (7) 3.50 (7) 
Lymphoma 1.0 mM 10.0 mM 10.471 (6) 3.71 (6) 
Spleen 1.0 mM 5.0 mM 6.592 (2) 9.92 (2) 
Spleen 1.0 mM 10.0 mM 11.976 (2) 9.92 (2) 
TABLE III (Continued) 
Tissue 
Concentration 
of EDTA in mM 
Concentration 





Embryo 1.0 mM 5.0 mM 11.061 (2) 9.92 (2) 
Embryo 1.0 mM 10.0 mM 6.055 (2) 9.92 (2) 
Placenta 1.0 mM 5.0 mM 6.102 (3) 5.81» (3) 
Placenta 1.0 mM 10.0 mM 6.1*27 (3) 5.81» (3) 
* Figures in parentheses ( ) indicate degrees of freedom. ro 
co 
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Figure 7 shows the inhibitory effect of 0.1 mM EDTA 
on the APase activities of normal tissues as compared to 
the average of leukemic values and the reversal of this 
inhibition with the addition of magnesium ions in 5.0 mM 
and 10.0 mM final concentrations. Table 3 also shows that 
the reversal is significant in the normal tissues. The data 
in Table 1 show that there is no significant difference 
between the APase activities of the normal tissues and leu¬ 
kemic tissues according to the extent of their reversal with 
added magnesium ions (p > 0.01). 
Figure 8 shows the inhibitory effect of 1.0 mM EDTA on 
leukemic APases and the average of leukemic values. The 
inhibition is reversed by 5-0 mM and 10.0 mM magnesium ions. 
The data in Table 3 show that there is significant reversal 
by both the concentrations of magnesium ions (p < 0.01). 
Figure 9 shows the inhibitory effect of 1.0 mM EDTA 
concentration on the normal tissues and the average of leu¬ 
kemic values and its reversal with added magnesium ions at 
5.0 mM and 10.0 mM final concentrations. The reversal 
effect is significant in all four tissues (p < 0.01, Table 
3). As shown in Table 1 there is no significant difference 
between the normal tissue APase activities and the leukemic 
tissue APase activities according to the extent of their 
reversal with added magnesium ions (p > 0.01). 
Fig. 7. Inhibition by 0.1 mM EDTA of the alkaline 
phosphatase activity of the normal tis¬ 
sues as compared to the average of leu¬ 
kemic values and its reversal with mag¬ 
nesium ions. AL represents the average 
of leukemic values which is the same as 
used in Fig. 6. The normal tissues in¬ 
cluded were adult spleen (S), 16-day 
embryo (E) and 16-day placenta (P). 
The magnesium ions were used in 5.0 mM 
and 10.0 mM final concentrations respec¬ 
tively. The experiments were performed 
at 37 C for 30 minutes with pNPP in a 
final concentration of 3.38 mM. In each 
tissue bar 1 represents EDTA alone; bar 
2 represents EDTA plus 5.0 mM magnesium 
chloride bar; and 3 represents EDTA plus 


















AL S E P 
Fig. 8. Inhibition by 1.0 mM EDTA of the alkaline 
phosphatase activity of the leukemic tis¬ 
sues and its reversal with magnesium ions. 
AL represents the average of leukemic val¬ 
ues; H-98 and U-l were virus-induced tumors., 
H-253 was a cell-transferred tumor; H-117 was 
a spontaneous tumor; and H-58 was a 6-mercap- 
topurine-induced tumor. The magnesium ions 
were used in 5-0 mM and 10.0 mM final concen¬ 
trations respectively. The experiments were 
performed at 37 C for 30 minutes with pNPP in 
a final concentration of 3.38 mM. In each 
tissue bar 1 represents EDTA alone; bar 2 
represents EDTA plus 5.0 mM magnesium chloride; 
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Fig. 9. Inhibition by 1.0 mM EDTA of the alkaline 
phosphatase activity of the normal tissues 
as compared to the average of leukemic val¬ 
ues and its reversal with magnesium ions. 
AL represents the average of leukemic values 
which is the same as used in Fig. 8. The 
normal tissues included were adult spleen 
(S), 16-day embryo (E) and 16-day placenta 
(P). The magnesium ions were used in 5*0 mM 
and 10.0 mM final concentrations respec¬ 
tively. The experiments were performed at 
37 C for 30 minutes with pNPP in a final 
concentration of 3.38 mM. In each tissue 
bar 1 represents EDTA alone; bar 2 represents 
EDTA plus 5-0 mM magnesium chloride; and bar 








DISCUSSION AND CONCLUSIONS 
Inhibitors have been used extensively in the identifi¬ 
cation of isoenzymes of APase from different organ sources. 
In the present study zinc sulfate, L-phenylalanine and EDTA 
were used as inhibitors of APase isoenzymes from normal and 
leukemic tissues of C57B1 mice. The results with zinc sul¬ 
fate were particularly significant and gave 32$ and 56$ 
inhibition of APase activity of whole embryo and placenta, 
respectively; the spleen and leukemic tissue APase activi¬ 
ties were not affected. L-phenylalanine partially inhibited 
normal and leukemic APase activities and did not show any 
preferential inhibition as reported by Fishman, et al. 
(1962) for rat intestine APase. EDTA in both the concen¬ 
trations being used in these experiments (0.1 mM and 1 mM) 
was inhibitory for APase activities of both normal and leu¬ 
kemic tissues. This inhibition was reversed with the exoge¬ 
nous addition of magnesium ions at 5.0 mM and 10.0 mM con¬ 
centrations . 
Abul-Fadl and King (19^9) and Hoare and Delory (1955) 
have shown that APase from ox kidney and sodium cyanide- 
treated ox kidney APases are inhibited by zinc sulfate. 
Fishman et al. (1962) have shown that APase from bone, lung, 
liver, and kidney are inhibited by zinc while intestinal and 
blood serum APases are not. The results of Clark and 
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Porteous (1965) showed that zinc is a powerful inhibitor of 
APase from the rabbit small intestine. According to Hoare 
and Delory (1955) the exogenous zinc ions lead to inhibi¬ 
tion because of their non-specific effect on proteins. 
L-phenylalanine has been used by Fishman et al. (1963) 
as an organ specific, stereospecific inhibitor of human and 
rat intestinal APase isoenzymes. Our results correspond 
with Brunei and Cathala (1971) who obtained 38% inhibition 
of beef brain APase with L-phenylalanine and with Belle 
(1972) in the sense that he could not distinguish APase 
isoenzymes from different canine tissues on the basis of L- 
phenylalanine inhibition. Eaton and Moss (1967) reported 
that L-phenylalanine inhibits orthophosphatase and pyro¬ 
phosphatase activities of human intestinal APase but does 
not affect either activity of the liver enzyme. Floyd 
(1973) has shown that in C57B1 mice orthophosphatase and 
pyrophosphatase activities reside in different molecules. 
EDTA has been used extensively as an inhibitor of APase 
from different sources. Trubowitz et al. (1957) reported 
that EDTA inhibited APase activity from human leukocytes. 
Mathies (1958) used EDTA to show the inhibition of his 
purified swine kidney APase. Clark and Porteous (1965) 
reported that EDTA dialyzed APase can not be activated with 
zinc or magnesium ions alone but both must be present and 
especially zinc should not exceed an optimum limit. 
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Agus et al. (1966) reported the cysteine inhibition of 
human kidney APase. According to his results cysteine 
inhibition can be reversed by dialysis or passage through 
coarse grade sephadex, while EDTA inhibition requires the 
readdition of zinc or magnesium ions. These results cor¬ 
respond with our work as far as reversal of EDTA inhibition 
with magnesium ions are concerned. 
Support for our results with magnesium ion activation 
of APase from normal and leukemic tissues come from the 
work of Fischer and Greep (19^8) who have reported the mag¬ 
nesium ion activation of intestinal APase. Abul-Fadl and 
King (19^9) showed that magnesium ions activate kidney 
APase. Hoare and Delory (1955) working with ox kidney 
APase reported the activation of cyanide-treated APase with 
magnesium ion. Fishman et al. (1962) reported magnesium 
ion activation of bone, kidney, lung, blood, intestine and 
liver APases. Eaton and Moss (1967, 1968) have reported 
that magnesium ions activate the orthophosphatase activity 
but inhibit pyrophosphatase activity except in low concen¬ 
tration. This was true for human intestine, liver and bone 
APases. 
LagerlBf and Kaplan (1967) have demonstrated APase in 
the thymus of l6-day-old embryos by the use of histochemical 
methods. It disappears after this time period and then 
reappears in the thymic lymphomas. This observation, along 
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with the biochemical characterization of APase from normal 
and leukemic tissues by Lumb and Doell (1970), suggests 
that APase appears in the thymic lymphomas by the dere¬ 
pression of embryonic genes. Our zinc sulfate inhibition 
results support the observations of Lumb and Doell (1970). 
Derepression of the embryonic antigens in cancer and 
by tumor viruses have been reported in literature repeat¬ 
edly. Gold and Freeman (1965) reported the presence of 
specific carcinoembryonic antigens in human colon carcinoma. 
Kithier et al. (1966) have reported the appearance of 
fetal serum protein in the serum of primary liver car¬ 
cinoma-bearing patients and Stanislawski-Birencwajg et al. 
(1967) demonstrated fetal serum proteins in the serum of 
chemically induced primary liver carcinoma in rats. Hull 
et al. (1969) demonstrated alpha-fetoproteins in the serum 
of monkeys suffering from liver carcinomas. Pearson and 
Freeman (1968) have implicated polyoma viruses in the dere¬ 
pression phenomenon leading to the appearance of an embry¬ 
onic antigen. 
Recently Ambrose et al. (1971) have shown the resem¬ 
blance between tumor specific transplantation antigens 
(TSTA) produced by SVUO virus infection and the embryonic 
antigens. They have shown that neonatally SV40-infected 
hamster can be immunized against tumor formation with human 
embryo or hamster embryo cells. They have argued that 
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during embryonic life there is much less difference among 
the proteins of different animals if the concept that 
ontogeny repeats phylogeny is applicable at the molecular 
level. The immunization effect of fetal antigens indicate 
that tumor specific transplantation antigens appear as a 
result of derepression by tumor viruses. 
The differentiating zinc sulfate inhibition results 
have shown that APase from the leukemic tissues resemble 
that from the normal adult spleen. These results in light 
of those obtained by Lumb and Doell (1970) support their 
suggestion that APase in mouse lymphoma cells appears as a 
result of derepression of embryonic functions. 
CHAPTER VI 
SUMMARY 
1. Magnesium ions activate the APase activity of normal as 
well as leukemic tissues. No significant difference is 
found between the normal and leukemic tissue APases accord¬ 
ing to the extent of their activation by magnesium. 
2. EDTA is the strongest inhibitor of APase activity both 
from the normal and the leukemic tissues. 
3. L-phenylalanine partially inhibits the APase activity 
from all the tissues tested, but does not have a differen¬ 
tiating effect. 
4. Zinc sulfate has a differentiating inhibitory effect. 
It inhibits embryonic and placental APase activity, but 
does not inhibit spleenic and leukemic APases. 
5. Magnesium ions reverse the inhibitory effect of EDTA 
on APase activity in all the tissues tested. 
6. The experimental results of zinc sulfate inhibition 
studies have shown that normal adult spleen APase resembles 
the thymic lymphoma APase. These results in light of those 
obtained by Lumb and Doell (1970) support their suggestion 
that APase in thymic lymphoma is formed as a result of the 
derepression of embryonic functions. 
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